Funder
National Natural Science Foundation of China
National High Level Hospital Clinical Research Funding
CAMS innovation fund for medical science
National Key Research and Development Program of China
CAMS fund for Rare Diseases Research
Tsinghua university and PUMCH joint fund
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging. 2003;30(5):781–93.
2. Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES. The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging. 2014;4(5):426–34.
3. Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844–60.
4. Singh S, Poon R, Wong R, Metser U. [68Ga]Ga PET imaging in patients with neuroendocrine tumors: a systematic review and Meta-analysis. Clin Nucl Med. 2018;43(11):802–10.
5. Yang J, Kan Y, Ge BH, Yuan L, Li C, Zhao W. Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis. Acta Radiol. 2014;55(4):389–98.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献